There were an estimated 263 million cases reported by the World Health Organization in 2023, up from about 248 million cases ...

A breakthrough discovery in enzyme science could revolutionize the treatment of autoimmune disorders and other diseases tied ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Researchers at the University of Pennsylvania have introduced lab-engineered small extracellular vesicles to target tumors in ...

New research emphasizes the need for ongoing COVID-19 protection for people with weakened immune systems, with scalable tests ...

A unique reaction in which antibodies bind to other antibodies may help scientists at Scripps Research better understand how ...

Recent results raise hope of new "broad, pan-tumor platform" like Keytruda. The emerging drugs are bispecific antibodies that ...

Tissue processing advance can label proteins at the level of individual cells across whole, intact rodent brains and other large samples just as fast and uniformly as in dissociated single cells.

A new experimental vaccine could offer protection not only against many variants of SARS-CoV-2, but also other sarbecoviruses that could spill over from animals to humans.

Bispecific antibodies have altered the multiple myeloma (MM) treatment landscape, but some practices still lack enough familiarity with these therapeutics to deliver them in outpatient settings.